Skip to content

Drug interactions

Ledipasvir-sofosbuvir + Leniolisib

Severity: Moderate

Ledipasvir-sofosbuvir and Leniolisib: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Leniolisib inhibits BCRP and may raise exposure to BCRP substrates such as ledipasvir and sofosbuvir. The antivirals have a wide therapeutic margin, so the clinical effect is expected to be small.

What this interaction means in plain words

Ledipasvir-sofosbuvir and Leniolisib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Ledipasvir-sofosbuvir belongs to Anti Virals; Leniolisib belongs to Miscellaneous.

Evidence level: Low

Why it happens

Leniolisib inhibits BCRP, reducing efflux of ledipasvir/sofosbuvir and increasing exposure.

What to do

Coadministration is possible with monitoring for antiviral adverse effects such as fatigue, headache and nausea. Avoid it if a suitable alternative exists.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Ledipasvir-sofosbuvir and Leniolisib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Ledipasvir-sofosbuvir with Leniolisib?

MediHelp rates the interaction as moderate. Ledipasvir-sofosbuvir and Leniolisib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Leniolisib inhibits BCRP and may raise exposure to BCRP substrates such as ledipasvir and sofosbuvir. The antivirals have a wide therapeutic margin, so the clinical effect is expected to be small.

How serious is the interaction between Ledipasvir-sofosbuvir and Leniolisib?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Coadministration is possible with monitoring for antiviral adverse effects such as fatigue, headache and nausea. Avoid it if a suitable alternative exists.

What other medicines interact with Ledipasvir-sofosbuvir?

MediHelp also lists interactions of Ledipasvir-sofosbuvir with, for example, Fosphenytoin, Phenobarbital, Phenytoin. The full list is on the Ledipasvir-sofosbuvir page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in